Issued Patents All Time
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12350277 | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface | Charles BOSWORTH | 2025-07-08 |
| 11759472 | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface | Charles BOSWORTH | 2023-09-19 |
| 10751334 | Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions | — | 2020-08-25 |
| 10413535 | Pharmaceutical compositions comprising an integrin ALPHA4 antagonist for use in treating ocular inflammatory conditions | — | 2019-09-17 |
| 8101658 | Nitric oxide donating prostamides | Francesca Benedini, Stefano Biondi, Valerio Chiroli, Wesley Kwan Mung Chong, Liming Dong +4 more | 2012-01-24 |
| 7718656 | Prostaglandin derivatives | Francesca Benedini, Valerio Chiroli, Wesley Kwan Mung Chong, Michael NIESMAN, Ennio Ongini | 2010-05-18 |
| 7612082 | Prostaglandin EP4 antagonists | Larry A. Wheeler, Michael E. Garst, Yanbin Liang, David F. Woodward, Robert M. Burk +4 more | 2009-11-03 |
| 7273883 | Prostaglandin EP4 antagonist | David F. Woodward, Yariv Donde, Robert M. Burk | 2007-09-25 |
| 7217725 | Prostaglandin D2 antagonist | David F. Woodward, Yariv Donde, Robert M. Burk | 2007-05-15 |
| 7070768 | Method for imparting artificial tan to human skin | — | 2006-07-04 |
| 7045634 | Prostamide receptor antagonists | David F. Woodward | 2006-05-16 |
| 7019149 | Thromboxane ligands without blood clotting side effects | Robert M. Burk, David F. Woodward | 2006-03-28 |
| 6956057 | EP4 agonists as agents for lowering intraocular pressure | David F. Woodward, Robert M. Burk, Mark Holoboski, Mari Posner | 2005-10-18 |
| 6818779 | Thromboxane ligands without blood clotting side effects | Robert M. Burk, David F. Woodward | 2004-11-16 |
| 6713268 | Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation | David F. Woodward, Licheng Shi, Clayton S. Spada, Sheila Mac Neil, Linda C. Smith-Thomas | 2004-03-30 |
| 6462077 | Thromboxane ligands without blood clotting side effects | Robert M. Burk, David F. Woodward | 2002-10-08 |
| 6395787 | Ocular hypotensive lipids | David F. Woodward, Helen Usansky, Steven W. Andrews, Robert M. Burk, June Chen +1 more | 2002-05-28 |
| 6090845 | Thromboxane ligands | Robert M. Burk, David F. Woodward | 2000-07-18 |
| 6017953 | Thromboxane ligands | Robert M. Burk, David F. Woodward | 2000-01-25 |
| 5741812 | Thromboxane ligands without blood clotting side effects | Robert M. Burk, David F. Woodward | 1998-04-21 |
| 5652236 | Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors | — | 1997-07-29 |
| 5650431 | Thromboxane ligands without blood clotting side effects | Robert M. Burk, David F. Woodward | 1997-07-22 |
| 5602143 | Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors | — | 1997-02-11 |
| 5516791 | 7-[carboxyakyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1]octane and derivatives thereof | Robert M. Burk, David F. Woodward | 1996-05-14 |
| 5416106 | 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof | Robert M. Burk, David F. Woodward | 1995-05-16 |